Literature DB >> 10570193

Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.

M C Gauduin1, R L Glickman, S Ahmad, T Yilma, R P Johnson.   

Abstract

Immunization with live attenuated simian immunodeficiency virus (SIV) strains has proved to be one of the most effective strategies to induce protective immunity in the SIV/macaque model. To better understand the role that CD4(+) T helper responses may play in mediating protection in this model, we characterized SIV-specific proliferative and cytokine responses in macaques immunized with live attenuated SIV strains. Macaques chronically infected with live attenuated SIV had strong proliferative responses to SIV proteins, with stimulation indices of up to 74. The magnitude of the proliferative response to SIV Gag varied inversely with the degree of attenuation; Gag-specific but not envelope-specific responses were lower in animals infected with more highly attenuated SIV strains. SIV-specific stimulation of lymphocytes from vaccinated macaques resulted in secretion of interferon-gamma, IL-2, regulated-upon-activation, normal T cells expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta but not IL-4 or IL-10. Intracellular flow cytometric analysis documented that, in macaques vaccinated with SIVmac239Deltanef, up to 2% of all CD4(+)T cells were specific for SIV p55. The ability of live attenuated SIV to induce a strong, sustained type 1 T helper response may play a role in the success of this vaccination approach to generate protection against challenge with wild-type SIV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570193      PMCID: PMC24185          DOI: 10.1073/pnas.96.24.14031

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Characterization of SIV-specific CD4+ T-helper proliferative responses in macaques immunized with live-attenuated SIV.

Authors:  M C Gauduin; R L Glickman; S Ahmad; T Yilma; R P Johnson
Journal:  J Med Primatol       Date:  1999 Aug-Oct       Impact factor: 0.667

2.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules.

Authors:  A Lanzavecchia; E Roosnek; T Gregory; P Berman; S Abrignani
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

3.  Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in Spodoptera exigua larva: use in differential diagnosis between vaccinated and infected animals.

Authors:  S Ahmad; M Bassiri; A K Banerjee; T Yilma
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

4.  Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.

Authors:  U Dittmer; W Lüke; C Stahl-Hennig; C Coulibaly; H Petry; W Bodemer; G Hunsmann; G Voss
Journal:  J Med Primatol       Date:  1994-07       Impact factor: 0.667

5.  Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen.

Authors:  T Kawai; J Wong; J MacLean; A B Cosimi; S Wee
Journal:  Transplant Proc       Date:  1994-08       Impact factor: 1.066

6.  Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

Authors:  R P Johnson; J D Lifson; S C Czajak; K S Cole; K H Manson; R Glickman; J Yang; D C Montefiori; R Montelaro; M S Wyand; R C Desrosiers
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 8.  New concepts in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.

Authors:  S Ahmad; B Lohman; M Marthas; L Giavedoni; Z el-Amad; N L Haigwood; C J Scandella; M B Gardner; P A Luciw; T Yilma
Journal:  AIDS Res Hum Retroviruses       Date:  1994-02       Impact factor: 2.205

10.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Authors:  M D Daniel; F Kirchhoff; S C Czajak; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

View more
  24 in total

1.  Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.

Authors:  Barbara L Shacklett; Karen E S Shaw; Lou A Adamson; David T Wilkens; Catherine A Cox; David C Montefiori; Murray B Gardner; Pierre Sonigo; Paul A Luciw
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge.

Authors:  R K S Ahmed; B Makitalo; K Karlen; C Nilsson; G Biberfeld; R Thorstensson
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

3.  The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.

Authors:  Christiane Stahl-Hennig; Ralph M Steinman; Peter Ten Haaft; Klaus Uberla; Nicole Stolte; Sem Saeland; Klara Tenner-Racz; Paul Racz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  Using death to one's advantage: HIV modulation of apoptosis.

Authors:  T M Ross
Journal:  Leukemia       Date:  2001-03       Impact factor: 11.528

5.  Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.

Authors:  Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

6.  Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Authors:  Iole Macchia; Marie-Claire Gauduin; Amitinder Kaur; R Paul Johnson
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

7.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Tilahun D Yilma
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus.

Authors:  Klara Tenner-Racz; Christiane Stahl Hennig; Klaus Uberla; Heribert Stoiber; Ralf Ignatius; Jonathan Heeney; Ralph M Steinman; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

10.  Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1.

Authors:  Nadine C Salisch; Daniel E Kaufmann; Amany S Awad; R Keith Reeves; Daniel P Tighe; Yuan Li; Michael Piatak; Jeffrey D Lifson; David T Evans; Florencia Pereyra; Gordon J Freeman; R Paul Johnson
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.